A detailed history of Pdt Partners, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 19,634 shares of CPRX stock, worth $418,400. This represents 0.04% of its overall portfolio holdings.

Number of Shares
19,634
Holding current value
$418,400
% of portfolio
0.04%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.19 - $21.35 $298,240 - $419,185
19,634 New
19,634 $390,000
Q3 2022

Nov 14, 2022

BUY
$7.06 - $15.52 $54,700 - $120,248
7,748 Added 19.77%
46,943 $602,000
Q2 2022

Aug 15, 2022

BUY
$6.23 - $8.57 $2,977 - $4,096
478 Added 1.23%
39,195 $275,000
Q1 2022

May 16, 2022

BUY
$5.31 - $8.31 $205,587 - $321,738
38,717 New
38,717 $321,000
Q3 2020

Nov 16, 2020

SELL
$2.97 - $5.08 $822,393 - $1.41 Million
-276,900 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$3.48 - $5.05 $174,348 - $253,005
-50,100 Reduced 15.32%
276,900 $1.28 Million
Q1 2020

May 15, 2020

SELL
$2.61 - $5.21 $179,521 - $358,354
-68,782 Reduced 17.38%
327,000 $1.26 Million
Q4 2019

Feb 14, 2020

BUY
$3.67 - $5.7 $774,285 - $1.2 Million
210,977 Added 114.16%
395,782 $1.48 Million
Q3 2019

Nov 14, 2019

BUY
$3.89 - $7.43 $718,891 - $1.37 Million
184,805 New
184,805 $981,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.19B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.